Skip to main content

Table 2 Characteristics of studies included in the meta-analysis

From: Short-and long-term effects of ischemic postconditioning in STEMI patients: a meta-analysis

Author

Country

Year

Chest pain

Elapsed time (m)

Culprit lesion

Protocal

Endpoint

Follow-up

Staat

France

2005

≤12 h

NR

LAD (38/43); RCA (62/57)

60″/60″ × 4

CKAUC;peak CK; blush grade; STR

3d

Ma

China

2006

≤12 h

395 ± 150/426 ± 150

LAD (49/53); LCX (23/17); RCA (28/30)

30″/30″ × 3

peak CK;peak CK-MB; WMSI

7d;2 m

Ma

China

2007

≤12 h

NR

LAD (53/52); LCX (22/17); RCA (25/31)

30″/30″ × 3

peak CK;peak CK-MB; WMSI

7d;2 m

Yang

China

2007

NR

312 ± 48/264 ± 42

LAD (65/61); LCX (9/6); RCA (26/33)

30″/30″ × 3

peakCK; CKAUC;IS; LVEF

3d;1w

Laskey

USA

2008

≤6 h

228 ± 43/222 ± 54

LAD (100/100); LCX (0); RCA (0)

90″/180″ × 2

peak CK; STR

NR

Thibault

France

2008

≤6 h

283 ± 82/297 ± 104

NR

60″/60″ × 4

CKAUC; TnI;IS; LVEF

6 m;12 m

Lin

China

2010

≤12 h

NR

LAD (64/62); LCX (8/8); RCA (28/30)

30″/30″ × 3

TNFα; LV EF (7d、1y); WMSI

7d;1y

Lin

China

2010

≤12 h

NR

LAD (54/62); LCX (8/77); RCA (38/31)

60″/60″ × 3

TNFα;LV EF (7d、1y); WMSI

7d;1y

Lonborg

Denmark

2010

≤12 h

241 ± 148.9/255 ± 196

LAD (44/39); LCX (8/19); RCA (47/42)

30″/30″ × 4

IS;IS/AAR;LVEF;peak TnT

3 m

Sorensson

Sweden

2010

≤6 h

165 ± 63.7/185 ± 87.41

LAD (37/37); LCX (11/3); RCA (53/61)

60″/60″ × 4

IS/AAR; TnTAUC; LVEF

6-9d

Xue

China

2010

≤12 h

4.1 ± 3.0/5.4 ± 3.7

LAD (42/59); LCX (0); RCA (58/41)

60″/60″ × 4

CK-MB, IS, LVEF, STR

7d

Garcia

USA

2011

≤12 h

4.5/4.4

LAD (36/24); LCX (23/10); RCA (41/67)

30″/30″ × 4

peakCK; CK-MB;LVEF

3.4y

Liu

China

2011

≤12 h

312 ± 102/324 ± 108

LAD (53/59); LCX (10/12); RCA (37/29)

30″/30″ × 3

peak CK; Peak CK-MB; WMSI;LVEF; blush grade;IS

7d

Freixa

Spain

2012

≤12 h

326 ± 180/330 ± 211

LAD (51/39); LCX (NR) RCA (45/47)

60″/60″ × 4

peak CK; Peak CK-MB; TnT; STR; IS (7d,6 m)

7d;6 m

Tarantini

Italy

2012

≤6 h

212 ± 85/194 ± 80

LAD (41/44); LCX (18/8); RCA (41/49)

60″/60″ × 4

peak TnI; LVEF;IS;

30d

Thuny

France

2102

≤12 h

289 ± 31/215 ± 20

LAD (56/56); LCX (0/8); RCA (44/36)

60″/60″ × 4

IS;peak CK

3d

Zhao

China

2012

≤12 h

309 ± 201/404 ± 191

LAD (53/53); LCX:NR; RCA:NR

60″/60″ × 4

LVEF; WMSI

1w;6 m

Dwyer

Canada

2013

≤6 h

150 ± 70/170 ± 84

LAD (50/46); LCX:(12/14); RCA:(38/40)

30″/30″ × 4

IS; AAR; PeakCK; LVEF

3d

Elzbieciak

Poland

2013

≤12 h

225.6 ± 139.4/317.6 ± 195.8

LAD (100/100); LCX (0) RCA (0)

60″/60″ × 4

IS; AAR; PeakCK-MB; peak TnT; LVEF;IS/AAR

3d;6 m

Hahn

Korea

2013

≤12 h

196 ± 51/195 ± 171

LAD (47/45); LCX:(11/11); RCA:(42/44)

60″/60″ × 4

peakCK-MB; STR; blush grade

30d

Mewton

France

2013

≤12 h

289 ± 31 /215 ± 20

LAD (56/56); LCX (0/8); RCA (44/36)

60″/60″ × 4

LVEF;IS;IS/AAR

4d

Sorensson

Sweden

2013

≤6 h

165 ± 51/180 ± 84

LAD (33/37); LCX (9/3); RCA (57/60)

60″/60″ × 4

IS; LVEF

12 m

Dong

China

2014

≤12 h

300 ± 90/294 ± 66

LAD (56/43); LCX (6/10); RCA (38/47)

30″/30″ × 3

blush grade; STR; CK- MB; TnT; LVEF

7d;30d

Limalanathan

Norway

2014

≤6 h

NR

LAD (46/51); LCX (13/9); RCA (41/41)

60″/60″ × 4

IS (CECMR); STR; TnT; LVEF

2d;4 m

Waltenberger

Germany

2014

≤6 h

NR

LAD (28/26); LCX (NR); RCA (64/74)

30″/30″ × 10

CKAUC;IS; LVEF

4d;4 m;12 m

  1. NR,not related; LAD,left anterior descending branch; RCA,right coronary arterry; LCX,left circumflex artery; CK,creatine kinase; CKAUC,CK area under the curve; CK-MB,creatine kinase isoenzyme; STR,ST resolution; WMSI, wall motion score index; IS, infarct size; LVEF, left ventricular ejection fraction; TnI,troponin I; TNFα,tumor necrosis factor; AAR,area at risk; TnT, troponin T